Patients with CVEs recorded during the follow‐up had higher levels of Lp(a) [21.2(9.9–44.6) vs. 15.3(6.6–35.6) mg/dL], numbers of major ASCVD events (0.6 ± 0.8 vs. This evidence concerns the gene LPA and atherosclerosis.